Total Payments
$19,705
2024 Payments
$2,430
Companies
67
Transactions
1,377
Medicare Patients
4,942
Medicare Billing
$337,630
Payment Breakdown by Category
Food & Beverage$19,656 (99.8%)
Education$48.68 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,656 | 1,371 | 99.8% |
| Education | $48.68 | 6 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,966 | 154 | $0 (2024) |
| Novo Nordisk Inc | $1,440 | 91 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,366 | 127 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,211 | 71 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,138 | 75 | $0 (2024) |
| Amgen Inc. | $1,112 | 65 | $0 (2024) |
| PFIZER INC. | $1,051 | 82 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,048 | 86 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $903.95 | 67 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $843.52 | 72 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,430 | 142 | ABBVIE INC. ($355.36) |
| 2023 | $2,671 | 171 | ABBVIE INC. ($469.51) |
| 2022 | $2,665 | 187 | ABBVIE INC. ($462.45) |
| 2021 | $2,575 | 179 | AbbVie Inc. ($433.51) |
| 2020 | $1,470 | 105 | Janssen Pharmaceuticals, Inc ($145.82) |
| 2019 | $2,482 | 185 | Novartis Pharmaceuticals Corporation ($297.31) |
| 2018 | $2,839 | 204 | Boehringer Ingelheim Pharmaceuticals, Inc. ($289.23) |
| 2017 | $2,573 | 204 | AstraZeneca Pharmaceuticals LP ($303.75) |
All Payment Transactions
1,377 individual payment records from CMS Open Payments — Page 1 of 56
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.66 | General |
| 12/17/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: VACCINES | ||||||
| 12/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: PAIN | ||||||
| 12/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Oncology | ||||||
| 12/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Biological | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: DIABETES | ||||||
| 12/04/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: GALLSTONES | ||||||
| 12/02/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: VACCINE | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: ANTI-ANXIETY | ||||||
| 11/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.78 | General |
| 11/15/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: PAIN | ||||||
| 11/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $30.71 | General |
| Category: Biological | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.22 | General |
| 11/07/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $6.91 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: PSYCHIATRY | ||||||
| 11/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: PAIN | ||||||
| 10/31/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Insomnia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,179 | 1,670 | $311,680 | $58,621 |
| 2022 | 14 | 1,245 | 1,673 | $330,678 | $70,532 |
| 2021 | 14 | 1,152 | 1,625 | $317,573 | $67,159 |
| 2020 | 20 | 1,366 | 1,949 | $371,816 | $141,318 |
Total Patients
4,942
Total Services
6,917
Medicare Billing
$337,630
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 436 | 789 | $164,951 | $21,041 | 12.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 368 | 368 | $82,800 | $14,529 | 17.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 25 | 25 | $13,225 | $7,029 | 53.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 101 | 121 | $17,182 | $4,043 | 23.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 49 | 49 | $4,018 | $3,715 | 92.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 36 | 43 | $14,835 | $2,333 | 15.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 15 | 15 | $4,785 | $2,195 | 45.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 51 | 51 | $2,091 | $1,463 | 70.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 12 | 12 | $4,068 | $915.96 | 22.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 26 | 26 | $1,066 | $745.68 | 70.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 28 | 29 | $1,131 | $361.90 | 32.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 20 | $1,040 | $166.08 | 16.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 14 | 122 | $488.00 | $84.49 | 17.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 450 | 860 | $179,740 | $26,415 | 14.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 359 | 359 | $80,775 | $15,328 | 19.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 67 | 67 | $5,340 | $4,586 | 85.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 108 | 117 | $16,614 | $4,474 | 26.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 14 | 14 | $7,406 | $3,893 | 52.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 27 | 27 | $9,153 | $3,277 | 35.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 20 | 20 | $6,380 | $2,962 | 46.4% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 25 | 25 | $2,875 | $2,858 | 99.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 70 | 70 | $2,870 | $1,901 | 66.2% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 26 | 26 | $8,970 | $1,314 | 14.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $3,804 | $1,281 | 33.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 14 | $3,934 | $1,033 | 26.3% |
About Dr. Steven Geister, M.D
Dr. Steven Geister, M.D is a Internal Medicine healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2012. The National Provider Identifier (NPI) number assigned to this provider is 1265707327.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Geister, M.D has received a total of $19,705 in payments from pharmaceutical and medical device companies, with $2,430 received in 2024. These payments were reported across 1,377 transactions from 67 companies. The most common payment nature is "Food and Beverage" ($19,656).
As a Medicare-enrolled provider, Geister has provided services to 4,942 Medicare beneficiaries, totaling 6,917 services with total Medicare billing of $337,630. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Tulsa, OK
- Active Since 03/21/2012
- Last Updated 06/26/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1265707327
Products in Payments
- XARELTO (Drug) $798.04
- ENTRESTO (Drug) $797.66
- UBRELVY (Drug) $722.36
- JARDIANCE (Drug) $645.09
- JANUVIA (Drug) $642.89
- TRELEGY ELLIPTA (Drug) $627.68
- VRAYLAR (Drug) $528.17
- ELIQUIS (Drug) $422.31
- FARXIGA (Drug) $403.90
- BEVESPI AEROSPHERE (Drug) $375.57
- Kerendia (Drug) $368.95
- XIFAXAN (Drug) $356.89
- Veozah (Drug) $314.94
- CHANTIX (Drug) $281.92
- EVENITY (Biological) $279.06
- Prolia (Biological) $278.28
- Trintellix (Drug) $277.01
- REXULTI (Drug) $272.47
- LINZESS (Drug) $267.36
- TRULICITY (Drug) $266.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Tulsa
Dr. Anuj Malik, Md, MD
Internal Medicine — Payments: $559,128
Internal Medicine $559,128
Mousumi Som, Do, DO
Internal Medicine — Payments: $182,416
Internal Medicine $182,416
Madhuri Lad, D.o, D.O
Internal Medicine — Payments: $160,090
Internal Medicine $160,090
Jesse Richards, D.o, D.O
Internal Medicine — Payments: $147,415
Internal Medicine $147,415
Dr. Stacy Chronister, D.o, D.O
Internal Medicine — Payments: $118,921
Internal Medicine $118,921
Mr. Eugene Ichinose, M.d, M.D
Internal Medicine — Payments: $113,876
Internal Medicine $113,876